Showing results (21-30 of 108) with videos related to
Sort By:
Pageof 11
Anticancer Research|January 31, 2021
Impact of the Relative Dose Intensity of Neoadjuvant Chemotherapy With Anthracycline Followed by Taxane on the Survival of Patients With Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: The JONIE1 StudyAkimitsu Yamada, Kyoko Nakazawa, Kohei Akazawa, et al.European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|March 5, 2022
Older patients' experience of living with cognitive impairment related to hormone therapy for breast cancer: A qualitative studyYasuko Tenda, Mika Miyashita, Akimitsu Yamada, et al.Pathology, Research and Practice|March 1, 2025
H3K27me3-mediated regulation of PD-L1 expression in triple-negative breast cancer (TNBC)Jotaro Harada, Kei Kawashima, Yuka Matsubara, et al.American Journal of Cancer Research|July 11, 2022
The clinical relevance of unfolded protein response signaling in breast cancerMasanori Oshi, Arya Mariam Roy, Shipra Gandhi, et al.Annals of Surgical Oncology|June 21, 2025
Activated Hippo Pathway is Associated with a Worse Response to Trastuzumab and Worse Survival in HER2-Positive Breast CancerMasanori Oshi, Farhad Ghasemi, Akimitsu Yamada, et al.In Vivo (Athens, Greece)|March 4, 2022
Stratification of Prognosis by Biological Features Following Neoadjuvant Chemotherapy in Luminal Breast CancerShinya Yamamoto, Takashi Chishima, Yukako Shibata, et al.Asian Journal of Surgery|April 21, 2021
Evaluation of aesthetic outcomes of breast-conserving surgery by the surgeon, nurse, and patientsShinya Yamamoto, Takashi Chishima, Sadatoshi Sugae, et al.Cancer Diagnosis & Prognosis|July 2, 2025
Clinical Significance of HER2-low Expression in Triple-negative Breast Cancer: A Retrospective Multicenter StudyMahana Iwai, Yoshiya Horimoto, Rongrong Wu, et al.World Journal of Oncology|August 10, 2023
A Case of BRCA2-Pathogenic Variant Breast Cancer With Metachronous Endometrial Cancer and Pancreatic CancerMasanori Oshi, Akimitsu Yamada, Aki Kimura, et al.Breast Cancer Research and Treatment|January 12, 2022
Low RUFY3 expression level is associated with lymph node metastasis in older women with invasive breast cancerFernando A Angarita, Masanori Oshi, Akimitsu Yamada, et al.Pageof 11